Medicine - Oct 19
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping
Environment - Oct 18
Environment

According to the prevailing opinion, species-rich ecosystems are more stable against environmental disruptions such as drought, hot spells or pesticides.

Life Sciences - Oct 18
Life Sciences

Graphene has been hailed as the material of the future. As yet, however, little is known about whether and how graphene affects our health if it gets into the body.

    Selected Job Offers
    Computer Science/Telecom - 19.10
    Dozentin / Dozent mit Schwerpunkt Künstliche Intelligenz (70-100%) Hochschule Luzern
    Administration - 18.10
    Wissenschaftliche/r Mitarbeiter/in Gesundheitstourismus Hochschule für Technik und Wirtschaft HTW Chur
    Life Sciences - 17.10
    Postdoctoral position in molecular mircobiology University of Geneva
    Administration - 16.10
    Studiengangleitung BSc Business Information Technology (80−100 %) Fachhochschule Nordwestschweiz FHNW
    Mathematics - 16.10
    Statistik-Dozent/in mit Forschungserfahrung (70-100%) Hochschule Luzern
    Employers of the Week



    Next Registrations
    Innovation/Technology »» 31.10.2018
    CAS ETH in Mobilität der Zukunft: Systemaspekte Eidgenossische Technische Hochschule Zürich, ETHZ
    Medicine/Pharmacology »» 15.11.2018
    CAS Klinische Pharmazie Eidgenossische Technische Hochschule Zürich, ETHZ
    Architecture »» 01.01.2019
    MAS ETH in Architecture and Digital Fabrication (MAS ETH DFAB) Eidgenossische Technische Hochschule Zürich, ETHZ
    Architecture »» 01.01.2019
    MAS ETH in Architecture, Real Estate, Construction (MAS ETH ARC) Eidgenossische Technische Hochschule Zürich, ETHZ